Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Gammie, James S ^c   Li, Sen ^c   Zeevi, Adriana ^c   Demetris, Anthony J ^c   Ildstad, Suzanne T ^a   Pham, Si M ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NONE

Author keywords

Blood cells; Grafting; Immune system; Transplantation

Indexed keywords

TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CELL VIABILITY; CHIMERA; CONDITIONING; CONTROLLED STUDY; DRUG TOLERANCE; HEART GRAFT; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN GRAFT; WHOLE BODY RADIATION;

EID: 0344193617     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wallwork J. Risk factors for chronic rejection in heart and lungs: why do hearts and lungs rot? Clin Transplant. 1994;8:341-344.
2. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168-170.
3. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras: immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med. 1985;162:231-244.
4. Gammie JS, Li S, Colson YL, Demetris AJ, Neipp M, Ildstad ST, Pham SM. A partial conditioning strategy to achieve mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol. 1998;26: 927-935.
5. Kunz HW, Cortese Hassett AL, Inomata T, Misra DN, Gill TJ3d. The RT1. G locus in the rat encodes a Qa/TL-like antigen. Immunogenetics. 1989;30:181-187.
6. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969;57:225-229.
7. Billingham R. Free skin grafting in mammals. In: Billingham RE, Silvers WK, eds. Transplantation of Tissues and Cells. Philadelphia, Pa: Wistar Institute Press, 1961:1.
8. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324: 667-674.
9. Demetris AJ, Murase N, Ye Q, Galvao FH, Richert C, Saad R, Pham S, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE. Analysis of chronic rejection and obliterative arteriopathy: possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997;150: 563-578.
10. Billingham RE, Lamphin HG, Medawar PB, et al. Tolerance of homografts, twin diagnosis, and the freemartin conditions in cattle. Heredity. 1951;6:201.
11. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst. 1955;136:28-33.
12. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10. D2 - B10). J Immunol. 1986;136: 28-33.
13. Colson YL, Zadach K, Nalesnik M, Ildstad ST. Mixed allogeneic chimerism in the rat: donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation. 1995;60:971-980.
14. Youm W, Colson YL, Komatsu K, Ildstad ST, Yousem SA, Griffith BP, Pham SM. Mixed chimerism to achieve donor-specific transplantation tolerance for lung allografts in rats. Surgical Forum. 1994;45:271-273.
15. Kawai T, Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation. 1995;59:256-262.
16. Li H, Kaufman CL, Ildstad ST. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery. 1995; 118:192-197; discussion 197-198.
17. Ildstad ST, Bluestone JA, Sachs DH. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10. D2/nSn - C57BL/10Sn). J Exp Med. 1986;163:1343-1348.
18. Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med. 1991;114:954-955.
19. Helg C, Chapuis B, Bolle JF, Morel P, Salomon D, Roux E, Antonioli V, Jeannet M, Leski M. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation. 1994;58:1420-1422.
20. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature. 1986; 323:164-166.
21. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989;169:493-502.
22. Tomita Y, Sachs DH, Khan A, Sykes M. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation. 1996;61:469-477.
23. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem HP, Leisenring W, Shulman H. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood. 1997; 89:3048-3054.